https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/dubowitz-neuromuscular-centre-confirmed-centre-paediatric-clinical-and-research-excellence/
Dubowitz Neuromuscular Centre confirmed as Centre of Paediatric Clinical and Research Excellence
22 Mar 2016, 3:37 p.m.
The Dubowitz Neuromuscular Centre has been confirmed as a Centre of Paediatric Clinical and Research Excellence by Muscular Dystrophy UK. The centre, based at Great Ormond Street Hospital and the UCL Institute of Child Health (ICH), is one of only ten Centres of Excellence and is the sole Paediatric Centre of Clinical and Research Excellence. This award recognises centres with outstanding levels of specialist care for people living with muscle wasting conditions.
The Dubowitz Neuromuscular Centre is a leading clinical- and research centre specialising in neuromuscular disorders affecting children. The centre provides clinical assessments, diagnostic services, and advice on treatment and rehabilitation alongside clinical trials and basic research focusing on causes of neuromuscular diseases in childhood and identifying new therapeutic interventions. The status was awarded following a national audit carried out by Muscular Dystrophy UK, aimed at ensuring that high-quality care is provided to patients with muscle-wasting conditions.
Great Ormond Street BRC Theme Lead, Professor Francesco Muntoni, is Head of the Dubowitz Neuromuscular Centre, and also leads the Novel Therapies for Translation in Childhood Diseases and the Developmental Neuroscience Programme at the ICH. He is co-director of the MRC Centre for Neuromuscular Diseases at UCL.
Fourth Annual NIHR GOSH BRC Image Competition - A Moment of Discovery
The Research and Innovation Communications team at GOSH and the NIHR GOSH Biomedical Research team invite you to enter our Research and Innovation Showcase: A Moment of Discovery.
New hope to prevent blindness in children with rare genetic disease
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by Clinicians at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH).
GOSH only hospital outside of North America to receive innovation funding award for AI
GOSH has been awarded the Amazon Web Services IMAGINE Grant: Children’s Health Innovation Award, to support artificial intelligence (AI) development and drive progress for children’s healthcare.
New clinical trial at GOSH gives hope to children with aggressive blood cancer
Researchers at GOSH and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) are collaborating on a novel approach to clinical trials to give hope to children with an aggressive type of blood cancer, T-cell acute lymphoblastic leukaemia (T-ALL)